Nevertheless, CTC enrichment with EpCAM-coupled antibodies has demonstrated to be superior to other cytometric methods and to be a reliable method for CTC detection in metastatic CRC patients [12]. This evidence concerns the gene EPCAM and colorectal carcinoma.